Dare Bioscience (DARE)
0.72
+0.01 (1.41%)
Upcoming Events
Latest Headlines
Daré Bioscience gets $908K NIH grant for preterm birth program
August 31, 2026 8:44 AM - StreetInsider
Daré Bioscience Announces New NIH Funding Award for Approximately $908,000 to Advance DARE-PTB2 for the Prevention of Preterm Birth
August 31, 2026 8:44 AM - StreetInsider
Form SCHEDULE 13G Dare Bioscience, Inc. Filed by: Lind Global Fund III LP
August 28, 2026 4:01 PM - SEC Filing
Daré Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor “Why Now” On-Demand Series
August 27, 2026 9:01 AM - StreetInsider
Form S-1 Dare Bioscience, Inc.
August 26, 2026 5:16 PM - SEC Filing
Daré Bioscience publishes sildenafil cream Phase 1 data in menopause journal
August 26, 2026 8:45 AM - StreetInsider
Daré Bioscience’s Sildenafil Cream Data in Postmenopausal Women Published in Menopause - The Journal of The Menopause Society
August 26, 2026 8:45 AM - StreetInsider
Daré Bioscience CEO discusses pipeline and commercial shift
August 25, 2026 8:55 AM - StreetInsider
Daré Bioscience CEO Outlines Commercial Transformation, Pipeline Momentum and Potential Key Catalysts in Virtual Investor CEO Connect Segment
August 25, 2026 8:55 AM - StreetInsider
Form SCHEDULE 13G Dare Bioscience, Inc. Filed by: L1 Capital Global Opportunities Master Fund, Ltd.
August 24, 2026 4:10 PM - SEC Filing
Form D Dare Bioscience, Inc.
August 20, 2026 6:03 AM - SEC Filing
Form 253G2 Dare Bioscience, Inc.
August 19, 2026 4:59 PM - SEC Filing
DARÉ Bioscience CEO Sabrina Martucci Johnson Named to Forbes 2026 “50 Over 50: Innovation” List
August 18, 2026 9:02 AM - StreetInsider
Form 8-K Dare Bioscience, Inc. For: Aug 14
August 17, 2026 8:36 AM - SEC Filing
Form 424B5 Dare Bioscience, Inc.
August 17, 2026 8:30 AM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on Dare Bioscience (DARE)
August 17, 2026 6:50 AM - StreetInsider
Daré Bioscience prices $6M direct offering at $1.37 per share
August 14, 2026 12:45 PM - StreetInsider
Daré Bioscience Announces Pricing of $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
August 14, 2026 12:45 PM - StreetInsider
Dare Bioscience (DARE) Tops Q2 EPS by 11c
August 14, 2026 1:50 AM - StreetInsider
Form 10-Q Dare Bioscience, Inc. For: Jun 30
August 13, 2026 4:03 PM - SEC Filing
Form 8-K Dare Bioscience, Inc. For: Aug 13
August 13, 2026 4:03 PM - SEC Filing
Daré Bioscience Reports Second Quarter 2026 Results and Highlights Commercial Inflection as Multi-Product Women’s Health Strategy Advances
August 13, 2026 4:01 PM - StreetInsider
Daré Bioscience to Host Second Quarter 2026 Financial Results and Company Update Conference Call and Webcast on August 13, 2026
August 6, 2026 9:05 AM - StreetInsider
Daré Bioscience partners with MyMenopauseRx for telehealth access
July 28, 2026 8:34 AM - StreetInsider
Daré Bioscience Expands Access Options for DARE to PLAY™ and Specialized Menopause Care Through Strategic Collaboration with MyMenopauseRx
July 28, 2026 8:34 AM - StreetInsider
Form 8-K Dare Bioscience, Inc. For: Jul 24
July 24, 2026 9:01 AM - SEC Filing
Daré Bioscience Launches Nationwide Virtual Bus Tour Webinar Series to Showcase Commercial Strategy and Growth Opportunities
July 20, 2026 9:01 AM - StreetInsider
Dare Bioscience faces Nasdaq delisting over equity deficiency
July 17, 2026 4:10 PM - StreetInsider
Form 253G2 Dare Bioscience, Inc.
July 17, 2026 4:08 PM - SEC Filing
Form 8-K Dare Bioscience, Inc. For: Jul 13
July 17, 2026 4:07 PM - SEC Filing
Form 8-K Dare Bioscience, Inc. For: Jul 13
July 13, 2026 9:01 AM - SEC Filing
Daré Bioscience CEO, Sabrina Martucci Johnson, to Participate in Virtual Investor Closing Bell Event
July 9, 2026 8:43 AM - StreetInsider
Form 4 Dare Bioscience, Inc. For: Jun 30 Filed by: Grossman Jessica D.
July 2, 2026 4:22 PM - SEC Filing
Form 4 Dare Bioscience, Inc. For: Jun 30 Filed by: Kelley Susan L.
July 2, 2026 4:22 PM - SEC Filing
Form 4 Dare Bioscience, Inc. For: Jun 30 Filed by: Matz Gregory W
July 2, 2026 4:21 PM - SEC Filing
Form 4 Dare Bioscience, Inc. For: Jun 30 Filed by: RASTETTER WILLIAM H
July 2, 2026 4:21 PM - SEC Filing
Form 4 Dare Bioscience, Inc. For: Jun 30 Filed by: Steele Robin Joan
July 2, 2026 4:15 PM - SEC Filing
Daré Bioscience Announces Flora Sync LF5™ Is Now Available Through Its Direct-to-Consumer Platform
July 1, 2026 8:55 AM - StreetInsider
Daré Bioscience plans June 2026 launch of vaginal probiotic product
June 25, 2026 9:05 AM - StreetInsider
Daré Bioscience Highlights Revenue Opportunity as CEO Discusses Upcoming Launch of Flora Sync LF5™ in Virtual Investor “What This Means” Segment
June 25, 2026 9:05 AM - StreetInsider
Form S-8 Dare Bioscience, Inc.
June 23, 2026 4:06 PM - SEC Filing
Form 8-K Dare Bioscience, Inc. For: Jun 22
June 22, 2026 9:01 AM - SEC Filing
Daré Bioscience to Showcase Leadership in Women's Health Innovation at BIO International Convention 2026
June 18, 2026 9:20 AM - Globe NewsWire
Daré Bioscience to Showcase Leadership in Women's Health Innovation at BIO International Convention 2026
June 18, 2026 9:20 AM - StreetInsider
Form 8-K Dare Bioscience, Inc. For: Jun 11
June 12, 2026 4:01 PM - SEC Filing
Form 4 Dare Bioscience, Inc. For: Jun 11 Filed by: RASTETTER WILLIAM H
June 11, 2026 5:05 PM - SEC Filing
Form 4 Dare Bioscience, Inc. For: Jun 11 Filed by: Kelley Susan L.
June 11, 2026 5:04 PM - SEC Filing
Form 4 Dare Bioscience, Inc. For: Jun 11 Filed by: Steele Robin Joan
June 11, 2026 4:59 PM - SEC Filing
Form 4 Dare Bioscience, Inc. For: Jun 11 Filed by: Matz Gregory W
June 11, 2026 4:52 PM - SEC Filing
Form 4 Dare Bioscience, Inc. For: Jun 11 Filed by: Grossman Jessica D.
June 11, 2026 4:48 PM - SEC Filing
Full Article List
